
Foreign pharmaceutical companies supplying cancer drugs to Russia spend about $500 million a year on “bonuses” for intermediaries, suppliers, and staff at Russian hospitals, according to a new investigation by Proekt.
meduza.io ↗Western pharmaceutical companies spend up to $500 million a year on bribes in Russia — with Putin’s allies cashing in, Proekt investigation finds — Meduza


